[Dosage and kinetics of MMC release of a collagen implant used as a delivery device in glaucoma surgery in the rabbit eye]

J Fr Ophtalmol. 2006 Nov;29(9):1042-6. doi: 10.1016/s0181-5512(06)73893-1.
[Article in French]

Abstract

Purpose: To determine the absorption and the release of mitomycin-C from a collagen implant and tissue impregnation in the anterior structures of the rabbit eye.

Methods: Determining the quantity of mitomycin-C that a collagen implant can absorb with the difference between dry and soaked weight. Mitomycin-C release was measured in vitro using spectrophotometry. The measurement was repeated using a bioassay. Ocular tissue impregnation was determined in 12 eyes of six rabbits. Sclera, implant, aqueous, and ciliary body specimens were collected for concentration measurement using HPLC from 1 to 6 h after surgery.

Results: The mean mitomycin-C quantity absorbed in the implant was 3.22+/-0.2 microg. In vitro release was 0.13 mg/ml after 10 min and 0.05 microg/ml at 6 h. The bioassay showed almost no antifibrotic activity in sclera. In vivo release of mitomycin-C was high from the first to the sixth hour.

Conclusion: After filtering surgery, mitomycin-C in the collagen implant is clearly released and ocular tissues are effectively impregnated.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cicatrix / prevention & control
  • Collagen
  • Drug Delivery Systems*
  • Filtering Surgery* / adverse effects
  • Glaucoma / surgery*
  • Mitomycin / administration & dosage*
  • Mitomycin / pharmacokinetics*
  • Prostheses and Implants*
  • Rabbits

Substances

  • Mitomycin
  • Collagen